Hypotensive effect of S-adenosyl-L-methionine in hypertensive rats is reduced by autonomic ganglia and KATP channel blockers

Amino Acids. 2016 Jul;48(7):1581-90. doi: 10.1007/s00726-016-2213-4. Epub 2016 Apr 23.

Abstract

S-adenosyl-L-methionine (SAM) is an amino acid involved in a number of physiological processes in the nervous system. Some evidence suggests a therapeutic potential of SAM in hypertension. In this study we investigated the effect of intracerebroventricular (ICV) infusions of SAM on arterial blood pressure in rats. Mean arterial blood pressure (MABP) and heart rate (HR) were measured at baseline and during ICV infusion of either SAM or vehicle (aCSF; controls) in conscious, male normotensive Wistar Kyoto rats (WKY) and Spontaneously Hypertensive Rats (SHR). MABP and HR were not affected by the vehicle. WKY rats infused with SAM (10 μM, 100 μM and 1 mM) showed a biphasic hemodynamic response i.e., mild hypotension and bradycardia followed by a significant increase in MABP and HR. On the contrary, SHR infused with SAM showed a dose-dependent hypotensive response. In separate series of experiments, pretreatment with hexamethonium, a ganglionic blocker as well as pretreatment with glibenclamide, a KATP channel blocker reduced the hemodynamic effects of SAM. SAM may affect the nervous control of arterial blood pressure via the autonomic nervous system and KATP channel-dependent mechanisms.

Keywords: Blood pressure; Brain; Hypertension; S-adenosyl-L-methionine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects*
  • Ganglia, Autonomic / physiopathology*
  • Glyburide / pharmacology*
  • Male
  • Potassium Channel Blockers / pharmacology*
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • S-Adenosylmethionine / pharmacology*

Substances

  • Potassium Channel Blockers
  • S-Adenosylmethionine
  • Glyburide